Clinical Trials Logo
  1. Home
  2. Colorectal Cancer
  3. NCT00473941
  4. Details
NCT00473941 Clinical Trial

Life After Cancer: Behavioral Treatment Study to Improve Quality of Life

Colorectal Cancer Clinical Trial

Official title:
Expressive Writing and Adjustment to Colorectal Cancer

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00473941
Other study ID # 1R21CA107428-01A2
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 2005
Est. completion date August 2008

Study information
Verified date July 2022
Source Temple University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the study is to find new ways to improve the quality of life of people who have been treated for colon or rectal cancer.

Description:

Individuals who take part in the study can expect: Two Interviews: - To be interviewed by our research staff over the phone. The interviews will include questions about your current quality of life and health. Brief Writing in a Journal: - To write for 15 minutes twice a week for two weeks about aspects of your life.

Recruitment information / eligibility
Status Completed
Enrollment 193
Est. completion date August 2008
Est. primary completion date August 2008
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Treated for stage I, II or III colon or rectal cancer in the past 5 years - Completed surgical treatment - Must be able to read and write in English Exclusion Criteria: - History of other cancers, with the exception of non-melanoma skin cancer

Study Design

Related Conditions & MeSH terms

Intervention

Behavioral:
• Expressive writing
Behavioral intervention using writing about cancer to improve quality of life outcomes

Locations
Country Name City State
United States Temple University Philadelphia Pennsylvania

Sponsors (1)
Lead Sponsor Collaborator
Temple University

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Depressive symptoms self-report depressive symptoms 2-Weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05400122 - Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer Phase 1
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Completed NCT00098787 - Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT05425940 - Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer Phase 3
Suspended NCT04595604 - Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery. N/A
Completed NCT03414125 - Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening N/A
Completed NCT02963831 - A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies Phase 1/Phase 2
Recruiting NCT05489211 - Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) Phase 2
Terminated NCT01847599 - Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib N/A
Completed NCT05799976 - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure N/A
Recruiting NCT03874026 - Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients Phase 2
Active, not recruiting NCT03170960 - Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors Phase 1/Phase 2
Completed NCT03167125 - Participatory Research to Advance Colon Cancer Prevention N/A
Completed NCT03181334 - The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation N/A
Recruiting NCT04258137 - Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study N/A
Recruiting NCT05568420 - A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
Recruiting NCT02972541 - Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer N/A
Completed NCT02876224 - Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors Phase 1
Completed NCT01943500 - Collection of Blood Specimens for Circulating Tumor Cell Analysis N/A

External Links